#tumorboardtuesday — Public Fediverse posts

#TumorBoardTuesday

There have been some exciting updates this weekend at #AACR23 on DDR and Breast Cancer‼️

So the discussion🗣️by @JenniferLitton & @marijasullivan tomorrow, 04/18/2023 at 8PM on treating early stage BRCA-mutated Breast Cancer is very timely⏲️

#TumorBoardTuesday

There have been some exciting updates this weekend at #AACR23 on DDR and Breast Cancer‼️

So the discussion🗣️by @JenniferLitton & @marijasullivan tomorrow, 04/18/2023 at 8PM on treating early stage BRCA-mutated Breast Cancer is very timely⏲️

💃🏻The above & upcoming #TumorBoardTuesday discussion with moderators @drsarahsam @PTarantinoMD is provided by @IntegrityCE

🕺🏻Supported by educational grants from @AstraZeneca @DaiichiSankyoUS Merck Sharp & Dohme Corp

More info about our free CME & MOC: http://integrityce.com/tbt

#TumorBoardTuesday
👉🏽#CME🔗 http://integrityce.com/tbt

😀We are looking forward to the🗣️on CDK4/6 inhibitors led by @PTarantinoMD & @drsarahsam Tuesday 02.28.23 at 8pm ET

🙋‍♂️BUT b4⃣ the🗣️, we want to know who you are‼️

👉🏽Please tell us where you are in your🩺journey🛣️
👇🏽👇🏽👇🏽

💎Tuesday 02.28.23 at 8pm ET @drsarahsam @PTarantinoMD takes us through CDK 4/6 inhibitors for #BreastCancer

💬Join us here on #TumorBoardTuesday!

🧠While we finalize the case details, collect FREE #CME (AMA & MOC)

👉🏽http://integrityce.com/tbt 👈🏼 #OncTwitter

#TumorBoardTuesday
👉🏽#CME🔗 http://integrityce.com/tbt

😀We are so glad to have you join into the discussion🗣️with @NarjustFlorezMD and @ShrutiPatelMD on IO combos for #NSCLC 🙏

🙋‍♂️BUT - we want to know who you are‼️

👉🏽So, please tell us where you are in your🩺journey🛣️
👇🏽👇🏽👇🏽

Set a ⏲ to join #TumorBoardTuesday on 02.21.23 at 8pm ET

👩🏻‍⚕️@NarjustFlorezMD @ShrutiPatelMD👩🏽‍⚕️
📰Options for IO combos for treatement of #NSCLC

🫁While we finalize the case, collect FREE #CME (AMA & MOC)

👉🏽http://integrityce.com/tbt 👈🏼#OncTwitter #LungCancer #LCSM

🚨AWESOME networking op for #oncology fellows!🚨

@TumorBoardTues is 👀for fellows interested in precision onc & immunotx to pair up w faculty around the 🌎 to co-lead cases.

Tell us what you're interested in, and we'll find a mentor for you to present with! #MedTwitter
---
RT @TumorBoardTues
#TumorBoardTuesday
📢CALLING ALL FELLOWS📢

➡️Would you like to co-lead a @TumorBoardTues case discussion in 2023❓❓❓

👉Fill out this BRIEF survey📃…
https://twitter.com/TumorBoardTues/status/1626346939267571714

3/#TumorBoardTuesday #gyncsm #OncTwitter

🤔Missed the #EndometrialCancer #MedTweetorial earlier this wk?
🤯Feeling left behind?

Don't fret, it's here📍

---
RT @BonumCe
1/ #OncTwitter #TumorBoardTuesday
✅#EndometrialCancer #MedTweetorial🧵
w @DrMMurphy @MeganLeigh127 @TumorBoardTues

🧬Tx response
🧪Trial results
🔬Tox for TKI-ICI

🆓#CME 🔗 http://bit.ly/3VBGJEJ
Supported by educational grants from Eisai & @Merck
https://twitter.com/BonumCe/status/1615519240542646275

💥#EndometrialCancer TKI/IO safety data & AE mgmt webinar 💥┈┈┈ w @DrMMurphy & @drteplinsky ┈┈┈🔹#CME info 👉 http://bit.ly/3Vqtabi 👈 @BonumCe ┈┈┈🔸Supported by edu grants from Eisai & @Merck 🔹#TumorBoardTuesday #gyncsm #OncTwitter https://twitter.com/i/broadcasts/1yoJMZrrqbNxQ

5...4...3...2...1...it's the final countdown
⏰30m warning
🔥#EndometrialCancer #webinar w @DrMMurphy & @drteplinsky🔥

👩‍🏫B4 we begin...👩🏻‍🏫
✅Answer #PreTest polls 👇
🔁Retweet & tag colleagues

#TumorBoardTuesday #OncTwitter #MedTwitter #GynCSM #gynonc

---
RT @TumorBoardTues
2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc
#CME🔗http://bit.ly/3YRDkog

🟢#PreTest Q 1️⃣
📊Diarrhea, nausea, & vomiting are common GI toxicities associated w…
https://twitter.com/TumorBoardTues/status/1616204008028528643

25/ #TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

#CME➡️http://bit.ly/3jCyVFJ 🏆

🔴Post Poll 3️⃣
🔴During tx w/ pembro-lenva, a pt develops grade 3 HTN requiring reduction in lenva. Starting dose of lenva was 20mg.

Which dose is recommended for lenva now?

25/ #TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc

#CME➡️http://bit.ly/3jCyVFJ 🏆

🔴Post Poll 3️⃣
🔴During tx w/ pembro-lenva, a pt develops grade 3 HTN requiring reduction in lenva. Starting dose of lenva was 20mg.

Which dose is recommended for lenva now?

#TumorBoardTuesday #PreTest Q2️⃣ @PGrivasMDPhD @rafee_talukder @MPishvaian @JohnEbbenMDPhD #UrothelialCancer
👉🏽Free #CME🔗: http://integrityce.com/tbt
👉🏽CME Eval 🔗http://integrityce.com/tbtEval

How would you manage a Pt who presents with dry eyes and blurred vision while on erdafitinib❓

#TumorBoardTuesday #PreTest Q1️⃣
Free #CME🔗:http://integrityce.com/tbt

🤔B4⃣ @PGrivasMDPhD @rafee_talukder🗣️FGFR3 as a🎯in met Bladder Ca, test your🧠with these 2❓s:

Which💊would you choose for a 74yo♂️ with G2 neuropathy & FGFR3 mut➕met bladder Ca s/p Gem-cis⏩maint avelumab❓

❄️The above & upcoming #TumorBoardTuesday discussion with moderator @PGrivasMDPhD @rafee_talukder is provided by @IntegrityCE

❄️Supported by educational grants from @AstraZeneca, Exelixis, & Merck Sharp & Dohme Corp

❄️More info about our free CME & MOC: http://integrityce.com/tbt

👉🏽#CME🔗 http://integrityce.com/tbt

📊1 way #TumorBoardTuesday gathers input is with polls, so be sure to tick your box!

👨🏻‍⚕️Before @PGrivasMDPhD @rafee_talukder take us through treatment options for mutated advanced #UrothelialCancer

🧐Tell us where you are in your 🩺journey
👇🏽👇🏽

#TumorBoardTuesday
@PGrivasMDPhD & @rafee_talukder

📅Tuesday 01/10/23 at🕗8PM ET
✅polls
⚖️Weigh in
🧾Bring citations
🔁Retweet
🏷️tag your🩺colleagues
🏆Earn your🆓CME (AMA & MOC) http://integrityce.com/tbt

B4⃣ the case:
🧐Tell us where you are in your🩺journey
👇🏽👇🏽👇🏽

#TumorBoardTuesday #UrothelialCancer

OK all, the holidays are over & it's time to dive back into the🧑‍🎓. We are starting 2023💪with a close🔬at🎯FGFR3 in met bladder Ca

📢Join us Tuesday 01/10/23 at 8pm ET when @PGrivasMDPhD & @rafee_talukder lead the🗣️
✅Prepare your Q’s NOW

We’re kicking off year 3 of #TumorBoardTuesday with an 💥EPIC💥 #UroOncology duo from @UWMedicine!!

👨🏻‍⚕️@PGrivasMDPhD @rafee_talukder
📅Tuesday 01/10/23 at 8PM ET
📊polls
⚖️in & bring citations🧾
🔁Retweet & tag colleagues
🏆Earn your 🆓 CME & MOC
http://integrityce.com/tbt

Please join us for the first #TumorBoardTuesday of 2023!!

@tompowles1 @PBarataMD @FedGhali @TomJayram @arnabguonc @sonpavde @nataliagandur @LauraEsfeller @dawood_findakly @mtsiatas @RCCadvocate @AmandaNizamMD @QingZhangLab @PavlosMsaouel @OAlhalabiMD @uwradonc @UWMedicine

We’re baaaack!!
📆Tuesday 01.10.23 at 8pm ET @PGrivasMDPhD @rafee_talukder take us through treatment options for met #UrothelialCancer

💬Join us here on #TumorBoardTuesday!

🧠While we finalize case details, collect FREE #CME (AMA & MOC)

👉🏽http://integrityce.com/tbt 👈🏼 #OncTwitter

9/#TumorBoardTuesday #OncTwitter #NephTwitter #BonumCE

#ICYMI 🪡#RenalCell #MedTweetorial🧵
w @brian_rini @shilpaonc @katy_beckermann

🦺TKI/IO safety data
🥽Tox to look 4
⛑AE mgmt

---
RT @TumorBoardTues
1/ #OncTwitter #NephTwitter #TumorBoardTuesday
✅#RenalCell #MedTweetorial🧵
w @brian_rini @shilpaonc @katy_beckermann

🦺TKI/IO safety data
🥽Tox to look 4
⛑AE mgmt

🆓#CME @BonumCe🔗http://bit.ly/3VDaK81
Support by edu grants from Eisai…
https://twitter.com/TumorBoardTues/status/1602468719426342913

8/ #TumorBoardTuesday #RenalCell #NephTwitter

🔴#PostTest Q 4️⃣
🗳️ Pt treated w/ combo of cabozantinib + nivolumab develops G3 hypertension. Cabo therapy is held & pt receives anti-hypertensive medication & BP recovers to baseline. At what dose can cabozantinib be restarted?

7/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE
#CME 🔗http://bit.ly/3FamQyu

🔴#PostTest Q3️⃣
🗳️ Pt treated w/ combo of pembrolizumab and lenvatinib for metastatic RCC develops grade 3 diarrhea. How might you diagnose which drug is causing this toxicity?

6/ #TumorBoardTuesday #OncTwitter #RenalCell #NephTwitter #MedTwitter #BonumCE
#CME 🔗http://bit.ly/3FamQyu

🔴#PostTest Q 2️⃣
🗳️ Which of the following is NOT a characteristic of immune-mediated toxicities associated with the use of ICIs?

4/ #TumorBoardTuesday #BonumCE
#RenalCell #NephTwitter #MedTwitter

Let’s revisit efficacy of 🔑Ph3 clin trials:
💎#CLEAR
💎#KEYNOTE426
💎#CheckMate9ER
💎#CheckMate214

3/ #TumorBoardTuesday #RCC #NephTwitter #MedTwitter #OncTwitter

🟠Earn 🆓 #CME 🏆
🟠CME ℹ️🔗http://bit.ly/3iLN6aX

📸 Faculty disclosures & important CME info 👇

⏰ Countdown to 8p ET has begun!
✅Answer #PreTest polls in the tweet below👇
🕗 Tune in w #TumorBoardTues & @shilpaonc @katy_beckermann & @brian_rini
🔁Retweet & tag colleagues🩺
🏆 Claim your CME

Simple as 🔢
---
RT @TumorBoardTues
1/🛎️#TumorBoardTuesday #OncTwitter #NephTwitter
#RenalCell wk continues🔁

🗓️Thu 12.15 @ 8p ET

⚙️Mnging AEs w TKI/IO combos

#CME ℹ️🔗http://bit.ly/3iLN6aX
Supported by edu grants from Eisai & @Merck
🚨Be rea…
https://twitter.com/TumorBoardTues/status/1603277070884216833

6/ #TumorBoardTuesday #RenalCell #NephTwitter

🟢#PreTest Q 4️⃣
📊Pt treated w/ combo of cabo + nivo develops G3 HTN. Cabo therapy is held & pt receives anti-hypertensive medication & BP recovers to baseline. At what dose can cabozantinib be restarted?

5/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

#CME 🔗http://bit.ly/3FbuEQx

🟢#PreTest Q 3️⃣
📊 Pt treated w/ combo of pembro & lenvatinib for mRCC develops grade 3 diarrhea. How might you diagnose which drug is causing this toxicity?

4/ #TumorBoardTuesday #RenalCell #NephTwitter #MedTwitter #BonumCE

#CME 🔗 http://bit.ly/3FbuEQx

🟢#PreTest Q 2️⃣
📊 Which of the following is NOT a characteristic of immune-mediated toxicities associated with the use of ICIs?

❄️ 1 hour until TONIGHT'S #TumorBoardTuesday!!

❄️ @shilpaonc takes us through treating clear cell #RenalCellCarcinoma

❄️ Snag some hot chocolate (+Bailey’s 😉), grab a blanket, and prepare your 🧠 with these #CME👇🏽See you soon!

---
RT @TumorBoardTues
#TumorBoardTuesday #PreTest❓Free #CME🔗: http://integrityce.com/tbt

🤔B4⃣ @shilpaonc🗣️management of #RenalCell🦀, test your🧠with these 2❓s:

Q1⃣: What Tx would you choose for a PS=2 hom…
https://twitter.com/TumorBoardTues/status/1602811547075624961

15/ #TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter

🟢Pt w mRCC
🔸Initiated tx w pembro + lenva
🔹Developed G3 diarrhea
🔸Lenva withheld & anti-diarrheal treatment initiated 🔹Diarrhea now resolved.

🟢What next step is best for the pt?

15/ #TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter

🟢Pt w mRCC
🔸Initiated tx w pembro + lenva
🔹Developed G3 diarrhea
🔸Lenva withheld & anti-diarrheal treatment initiated 🔹Diarrhea now resolved.

🟢What next step is best for the pt?

11/ #TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter

Some AEs attributable to either drug
These🔂overlapping tox can complicate pt mgmt

10/ #TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter

🟢Which of the following is an AE that is commonly observed with both ICIs and TKIs?

7/ #TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter

🟢Which of the following is a characteristic feature of the most common toxicities associated with anti-angiogenic therapies?

6/ #TumorBoardTuesday #BonumCE #OncTwitter #NephTwitter #MedTwitter #RenalCell

✳️Dual ICI combo (ipi + nivo) also approved tx option

💎#CheckMate214 - ipi + nivo vs sunitinib
✅Longest follow-up in frontline RCC (>5 years)
✅OS and PFS favor combo tx in int/poor risk pts

4/ #TumorBoardTuesday #BonumCE #OncTwitter #RenalCell

💎Combo txs as SOC for 1st line mRCC💎

TKI/ICI combos:
🔸#lenvatinib (TKI) + #pembrolizumab (PD-1 mAb)
🔸#axitinib (TKI) + pembro
🔸#cabozantinib (TKI) + #nivolumab (PD-1 mAb)

Dual ICI combo:
🔸#ipilimumab (CTLA-4) + nivo

4/ #TumorBoardTuesday #BonumCE #OncTwitter #RenalCell

💎Combo txs as SOC for 1st line mRCC💎

TKI/ICI combos:
🔸#lenvatinib (TKI) + #pembrolizumab (PD-1 mAb)
🔸#axitinib (TKI) + pembro
🔸#cabozantinib (TKI) + #nivolumab (PD-1 mAb)

Dual ICI combo:
🔸#ipilimumab (CTLA-4) + nivo

4/ #TumorBoardTuesday #BonumCE #OncTwitter #RenalCell

💎Combo txs as SOC for 1st line mRCC💎

TKI/ICI combos:
🔸#lenvatinib (TKI) + #pembrolizumab (PD-1 mAb)
🔸#axitinib (TKI) + pembro
🔸#cabozantinib (TKI) + #nivolumab (PD-1 mAb)

Dual ICI combo:
🔸#ipilimumab (CTLA-4) + nivo

3/ #TumorBoardTuesday #BonumCE #RenalCell
#OncTwitter #NephTwitter #MedTwitter

🟢 Which of the following TKI/IO combo regimens is 🚫NOT approved by the FDA for the frontline mgmt of #RenalCell carcinoma?

2/ #TumorBoardTuesday #BonumCE #RenalCell #OncTwitter #NephTwitter
🆓#CME info ➕ full ref list🗒️ 👉 http://bit.ly/3VDaK81

✳️The critical elements👇

1/ #OncTwitter #NephTwitter #TumorBoardTuesday
✅#RenalCell #MedTweetorial🧵
w @brian_rini @shilpaonc @katy_beckermann

🦺TKI/IO safety data
🥽Tox to look 4
⛑AE mgmt

🆓#CME @BonumCe🔗http://bit.ly/3VDaK81
Support by edu grants from Eisai & @Merck

🟢What's your specialty?

#TumorBoardTuesday @KlempnerSam
#PreTest Q 3⃣Free #CME🔗: http://integrityce.com/tbt

👉🏽CME Eval 🔗http://integrityce.com/tbtEval

What is the expected prevalence of CLDN18.2-high (CLDN18.2+) in advanced GC/GEJ cancers?

#TumorBoardTuesday @KlempnerSam
#PreTest Q 2️⃣ Free #CME🔗: http://integrityce.com/tbt

👉🏽CME Eval 🔗http://integrityce.com/tbtEval

How is CLDN18.2 tested for?

#TumorBoardTuesday #PreTest❓Free #CME🔗: http://integrityce.com/tbt

🤔B4⃣ @KlempnerSam🗣️Claudin 18.2🎯💊in upper GI Ca, test your🧠with these 3 Q's:

What did the addition of zolbetuximab add to chemotherapy in the Phase II FAST trial for advanced GC/GEJ patients?

🪵There’s been developments in testing & treating #GastricCancer/GEJ!!

🪓Join #TumorBoardTuesday on 12/06/22 at 8pm ET when @KlempnerSam takes us through potential approaches to clinical convos between patients & clinicians regarding claudin 18.2

🪵Prepare your own Q’s NOW

Set a ⏲ to join #TumorBoardTuesday on 12.06.22 at 8pm ET

📅Tues 12.06.22 at 8pm ET
👨🏻‍⚕️@KlempnerSam
📰Claudin 18.2 & new developments!!

🪵While we finalize the case, collect FREE #CME (AMA & MOC)

👉🏽http://integrityce.com/tbt 👈🏼#OncTwitter #GastricCancer